Overview
BNTC market data
Price History
BNTC price chart · 3M
- O
- 9.70
- H
- 9.77
- L
- 9.42
- C
- 9.64
- Vol
- 6,869.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $9.70
- Previous Close
- $9.62
- Day High
- $9.77
- Day Low
- $9.42
- 52 Week High
- $14.22
- 52 Week Low
- $9.34
- 7 Day Return
- -12.52%
- 30 Day Return
- -25.27%
- 90 Day Return
- -23.85%
- 1 Year Return
- -11.64%
- Daily Notional Volume
- $66.2K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.05 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.25 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -20,671.4% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $9.26 – $16.76 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- $24.33 Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $334.5M · P/B 1.45 · P/S 4,778.93.
Company News
6 captured
8-K filing — Benitec Biopharma Inc. (BNTC)SEC EDGAR ·
Benitec Biopharma Releases Full Year 2026 Financial Results and Provides Operational UpdateGlobenewswire Inc ·
Benitec Biopharma Q4 EPS $(0.26), InlineBenzinga ·